Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octagam 10% phase 2 study in mild to moderate Alzheimer's disease
2007-007134-19Phase 2Completed
- Sponsor
- Octapharma
- Start
- Aug 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Human normal immunoglobulin G in Alzheimer's disease (AD) (8 arms), sponsored by Octapharma. Started Aug 2008; status: completed.
02
Drugs
Human normal immunoglobulin G
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2007-007134-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007134-19.